Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Thomas Geisbert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of nanoparticle-based adjuvanted vaccine forthe prevention of Nipah virus infection
Geisbert, T. (PI)
EuBiologics Co Ltd ( Award # )
12/16/25 → 3/31/27
Project: Research project
-
Development of a Marburgvirus subunit vaccine adjuvanted with a novel TLR7/TLR8 agonist
Geisbert, T. (PI)
Abvacc ( Award #5R43AI18129202)
12/1/25 → 1/31/27
Project: Research project
-
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
Geisbert, T. (PI)
AbVacc ( Award #4R44AI17937102)
6/1/25 → 5/31/27
Project: Research project
-
Rapid Ecosystem for Agnostic Antibody DiscoverY (REAADY)
Geisbert, T. (PI)
Vanderbilt University Medical Center ( Award #W911SR2390017)
1/18/25 → 8/31/27
Project: Research project
-
Human Nanobides as Hantavirus Countermeasures
Geisbert, T. (PI)
Henry M. Jackson Foundation for the Advancement of Military Medicine ( Award #HU00012420061)
8/15/24 → 8/14/27
Project: Research project
-
Analysis of Recombinant Cedar Virus Infection and Cross-Protection Against Related Henipaviruses in African Green Monkeys
Pigeaud, D. D., Amaya, M., Borisevich, V., Fenton, K. A., Agans, K. N., Woolsey, C., Dimitrov, A. S., Prasad, A. N., Dobias, N. S., Deer, D. J., Geisbert, J. B., Cross, R. W., Broder, C. C. & Geisbert, T. W., Mar 2026, In: Viruses. 18, 3, 292.Research output: Contribution to journal › Article › peer-review
Open Access -
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challenge
Pigeaud, D. D., Borisevich, V., Agans, K. N., Harrison, M. B., O’Toole, R., Martinez, J., Dobias, N. S., Woolsey, C., Fenton, K. A., Geisbert, T. W. & Cross, R. W., Jan 3 2026, In: npj Vaccines. 11, 1, p. 21 21.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses
Gaisina, I. N., Argade, M. D., Bott, R., Bradley, S. P., Tomorowicz, Ł., Alvarez, M., Galván Achi, J. M., Cross, R. W., Borisevich, V., O’Toole, R., Amaya, M., Zielinski, C. A., Gaisin, A. M., Nikolic, D., Carlier, P. R., Anantpadma, M., Moore, T. W., Broder, C. C., Geisbert, T. W. & Peet, N. P. & 1 others, , Jan 22 2026, In: Journal of medicinal chemistry. 69, 2, p. 1264-1285 22 p.Research output: Contribution to journal › Article › peer-review
-
Hemorrhagic Fever Disease in STAT-1 Knockout Mice Infected with Lujo Virus
Johnson, D. M., Jan, S., Dunn, E., Comer, J. E., Cross, R. W. & Geisbert, T. W., Apr 2026, In: Pathogens. 15, 4, 394.Research output: Contribution to journal › Article › peer-review
Open Access -
Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challenge
Chapman, N. S., Borisevich, V., Kose, N., Myers, L., Priest, S., Bergeron, É., Esteban, E. T., Sánchez-Seco, M. P., Melero, J., Geisbert, T. W., Cross, R. W. & Crowe, J. E., Mar 31 2026, In: Journal of Clinical Investigation. 136, 10, e191440.Research output: Contribution to journal › Article › peer-review
Open Access